Lisdexamfetamine Dimesylate Effects on Binge Eating Behaviour and Obsessive-Compulsive and Impulsive Features in Adults with Binge Eating Disorder

European Eating Disorders Review

Volumn 24, Issue 3, 2016, Pages 223-231

  McElroy, Susan L ^a,b   Mitchell, James E ^c   Wilfley, Denise ^d   Gasior, Maria ^e   Ferreira Cornwell, M Celeste ^e   McKay, Michael ^e   Wang, Jiannong ^f   Whitaker, Timothy ^e   Hudson, James I ^g  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b LINDNER CENTER OF HOPE   (United States)

^c NEUROPSYCHIATRIC RESEARCH INSTITUTE   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e SHIRE   (United States)

^f CSL BEHRING   (United States)

^g MCLEAN HOSPITAL   (United States)

Author keywords

binge eating disorder; impulsivity; lisdexamfetamine dimesylate; obsessive compulsive

Indexed keywords

LISDEXAMFETAMINE; PLACEBO;

ADULT; ARTICLE; BARRATT IMPULSIVENESS SCALE; BINGE EATING DISORDER; BINGE EATING SCALE; CLINICAL TRIAL; COMPULSIVE PERSONALITY DISORDER; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; FEMALE; HUMAN; HUNGER; IMPULSIVENESS; INHIBITION (PSYCHOLOGY); MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE ASSESSMENT; OBSESSIVE COMPULSIVE DISORDER; QUESTIONNAIRE; TREATMENT DURATION; YALE BROWN OBSESSIVE COMPULSIVE SCALE; ADOLESCENT; BINGE-EATING DISORDER; BULIMIA; COMPULSION; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; FEEDING BEHAVIOR; MIDDLE AGED; MULTICENTER STUDY; OBSESSION; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; BINGE-EATING DISORDER; BULIMIA; COMPULSIVE BEHAVIOR; DOUBLE-BLIND METHOD; FEEDING BEHAVIOR; FEMALE; HUMANS; IMPULSIVE BEHAVIOR; LISDEXAMFETAMINE DIMESYLATE; MALE; MIDDLE AGED; OBSESSIVE BEHAVIOR; SEVERITY OF ILLNESS INDEX; SURVEYS AND QUESTIONNAIRES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84949496472     PISSN: 10724133     EISSN: 10990968     Source Type: Journal    
DOI: 10.1002/erv.2418     Document Type: Article

References (46)

1. Adler, L. A., Goodman, D. W., Kollins, S. H., Weisler, R. H., Krishnan, S., Zhang, Y., et al., (2008). Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder. Journal of Clinical Psychiatry, 69, 1364-1373.
2. American Psychiatric Association (2000). Diagnostic and statistical manual of mental disorders, fourth edition, text revision. Washington, DC: American Psychiatric Association.
3. American Psychiatric Association (2013). Diagnostic and statistical manual of mental disorders, fifth edition. Washington, DC: American Psychiatric Association.
4. Appolinario, J. C., Bacaltchuk, J., Sichieri, R., Claudino, A. M., Godoy-Matos, A., Morgan, C., et al., (2003). A randomized, double-blind, placebo-controlled study of sibutramine in the treatment of binge-eating disorder. Archives of General Psychiatry, 60, 1109-1116.
5. Bas, M., Bozan, N., &, Cigerim, N., (2008). Dieting, dietary restraint, and binge eating disorder among overweight adolescents in Turkey. Adolescence, 43, 635-648.
6. Bello, N. T., &, Hajnal, A., (2010). Dopamine and binge eating behaviors. Pharmacology Biochemistry and Behavior, 97, 25-33.
7. Berridge, K. C., Ho, C. Y., Richard, J. M., &, DiFeliceantonio, A. G., (2010). The tempted brain eats: Pleasure and desire circuits in obesity and eating disorders. Brain Research, 1350, 43-64.
8. Brewer, J. A., &, Potenza, M. N., (2008). The neurobiology and genetics of impulse control disorders: Relationships to drug addictions. Biochemical Pharmacology, 75, 63-75.
9. Claudino, A. M., de Oliveira, I. R., Appolinario, J. C., Cordas, T. A., Duchesne, M., Sichieri, R., et al., (2007). Double-blind, randomized, placebo-controlled trial of topiramate plus cognitive-behavior therapy in binge-eating disorder. Journal of Clinical Psychiatry, 68, 1324-1332.
10. Crow, S. J., Agras, W. S., Halmi, K., Mitchell, J. E., &, Kraemer, H. C., (2002). Full syndromal versus subthreshold anorexia nervosa, bulimia nervosa, and binge eating disorder: A multicenter study. International Journal of Eating Disorders, 32, 309-318.
11. Davis, C., Levitan, R. D., Kaplan, A. S., Carter, J., Reid, C., Curtis, C., et al., (2007). Dopamine transporter gene (DAT1) associated with appetite suppression to methylphenidate in a case-control study of binge eating disorder. Neuropsychopharmacology, 32, 2199-2206.
12. Deal, L., Wirth, R. J., Gasior, M., Herman, B. K., &, McElroy, S., (2015). Validation of the Yale-Brown obsessive compulsive scale modified for binge eating. International Journal of Eating Disorders, 48, 994-1004.
13. Fineberg, N. A., Potenza, M. N., Chamberlain, S. R., Berlin, H. A., Menzies, L., Bechara, A., et al., (2010). Probing compulsive and impulsive behaviors, from animal models to endophenotypes: A narrative review. Neuropsychopharmacology, 35, 591-604.
14. Galanti, K., Gluck, M. E., &, Geliebter, A., (2007). Test meal intake in obese binge eaters in relation to impulsivity and compulsivity. International Journal of Eating Disorders, 40, 727-732.
15. Goldfein, J. A., Devlin, M. J., &, Kamenetz, C., (2005). Eating Disorder Examination-Questionnaire with and without instruction to assess binge eating in patients with binge eating disorder. International Journal of Eating Disorders, 37, 107-111.
16. Goodman, W. K., Price, L. H., Rasmussen, S. A., Mazure, C., Fleischmann, R. L., Hill, C. L., et al., (1989). The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Archives of General Psychiatry, 46, 1006-1011.
17. Gormally, J., Black, S., Daston, S., &, Rardin, D., (1982). The assessment of binge eating severity among obese persons. Addictive Behaviors, 7, 47-55.
18. Heal, D. J., Cheetham, S. C., &, Smith, S. L., (2009). The neuropharmacology of ADHD drugs in vivo: Insights on efficacy and safety. Neuropharmacology, 57, 608-618.
19. Hsu, L. K., Mulliken, B., McDonagh, B., Krupa Das, S., Rand, W., Fairburn, C. G., et al., (2002). Binge eating disorder in extreme obesity. International Journal of Obesity and Related Metabolic Disorders, 26, 1398-1403.
20. Hudson, J. I., Hiripi, E., Pope, H. G. Jr., &, Kessler, R. C., (2007). The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication. Biological Psychiatry, 61, 348-358.
21. Kalarchian, M. A., Wilson, G. T., Brolin, R. E., &, Bradley, L., (1998). Binge eating in bariatric surgery patients. International Journal of Eating Disorders, 23, 89-92.
22. Kessler, R. C., Berglund, P. A., Chiu, W. T., Deitz, A. C., Hudson, J. I., Shahly, V., et al., (2013). The prevalence and correlates of binge eating disorder in the World Health Organization World Mental Health Surveys. Biological Psychiatry, 73, 904-914.
23. Marcus, M. D., Wing, R. R., &, Lamparski, D. M., (1985). Binge eating and dietary restraint in obese patients. Addictive Behaviors, 10, 163-168.
24. McElroy, S. L., Arnold, L. M., Shapira, N. A., Keck, P. E. Jr., Rosenthal, N. R., Karim, M. R., et al., (2003a). Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial. The American Journal of Psychiatry, 160, 255-261.
25. McElroy, S. L., Guerdjikova, A., Kotwal, R., Welge, J. A., Nelson, E. B., Lake, K. A., et al., (2007a). Atomoxetine in the treatment of binge-eating disorder: A randomized placebo-controlled trial. Journal of Clinical Psychiatry, 68, 390-398.
26. McElroy, S. L., Guerdjikova, A. I., Mori, N., &, O'Melia, A. M., (2012). Pharmacological management of binge eating disorder: Current and emerging treatment options. Therapeutics and Clinical Risk Management, 8, 219-241.
27. McElroy, S. L., Guerdjikova, A. I., Winstanley, E. L., O'Melia, A. M., Mori, N., McCoy, J., et al., (2011). Acamprosate in the treatment of binge eating disorder: A placebo-controlled trial. International Journal of Eating Disorders, 44, 81-90.
28. McElroy, S. L., Hudson, J. I., Capece, J. A., Beyers, K., Fisher, A. C., Rosenthal, N. R., et al., (2007b). Topiramate for the treatment of binge eating disorder associated with obesity: A placebo-controlled study. Biological Psychiatry, 61, 1039-1048.
29. McElroy, S. L., Hudson, J. I., Malhotra, S., Welge, J. A., Nelson, E. B., &, Keck, P. E. Jr., (2003b). Citalopram in the treatment of binge-eating disorder: A placebo-controlled trial. Journal of Clinical Psychiatry, 64, 807-813.
30. McElroy, S. L., Hudson, J. I., Mitchell, J. E., Wilfley, D., Ferreira-Cornwell, M. C., Gao, J., et al., (2015). Efficacy and safety of lisdexamfetamine for treatment of adults with moderate to severe binge-eating disorder: A randomized clinical trial. JAMA Psychiatry, 72, 235-246.
31. McElroy, S. L., Kotwal, R., Guerdjikova, A. I., Welge, J. A., Nelson, E. B., Lake, K. A., et al., (2006). Zonisamide in the treatment of binge eating disorder with obesity: A randomized controlled trial. Journal of Clinical Psychiatry, 67, 1897-1906.
32. McElroy, S. L., Phillips, K. A., &, Keck, P. E. Jr., (1994). Obsessive compulsive spectrum disorder. Journal of Clinical Psychiatry, 55, 33-51 discussion 52-33.
33. Nasser, J. A., Gluck, M. E., &, Geliebter, A., (2004). Impulsivity and test meal intake in obese binge eating women. Appetite, 43, 303-307.
34. Panagiotou, O. A., Contopoulos-Ioannidis, D. G., Papanikolaou, P. N., Ntzani, E. E., &, Ioannidis, J. P., (2011). Different black box warning labeling for same-class drugs. Journal of General Internal Medicine, 26, 603-610.
35. Patton, J. H., Stanford, M. S., &, Barratt, E. S., (1995). Factor structure of the Barratt impulsiveness scale. Journal of Clinical Psychology, 51, 768-774.
36. Pennick, M., (2010). Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine. Neuropsychiatric Disease and Treatment, 6, 317-327.
37. Schag, K., Schonleber, J., Teufel, M., Zipfel, S., &, Giel, K. E., (2013a). Food-related impulsivity in obesity and binge eating disorder-A systematic review. Obesity Reviews, 14, 477-495.
38. Schag, K., Teufel, M., Junne, F., Preissl, H., Hautzinger, M., Zipfel, S., et al., (2013b). Impulsivity in binge eating disorder: Food cues elicit increased reward responses and disinhibition. PLoS ONE, 8, e76542.
39. Stanford, M. S., Mathias, C. W., Dougherty, D. M., Lake, S. L., Anderson, N. E., &, Patton, J. H., (2009). Fifty years of the Barratt Impulsiveness Scale: An update and review. Personality and Individual Differences, 47, 385-395.
40. Stunkard, A. J., &, Messick, S., (1985). The Three-Factor Eating Questionnaire to measure dietary restraint, disinhibition and hunger. Journal of Psychosomatic Research, 29, 71-83.
41. Stunkard, A. J., &, Messick, S., (1988). Eating Inventory: Manual. San Diego, CA: Psychological Corporation, Harcourt Brace Jovanovich.
42. Timmerman, G., (1999). Binge eating scale: Further assessment of validity and reliability. Journal of Applied Biobehavioral Research, 4, 1-12.
43. Vannucci, A., Theim, K. R., Kass, A. E., Trockel, M., Genkin, B., Rizk, M., et al., (2013). What constitutes clinically significant binge eating? Association between binge features and clinical validators in college-age women. International Journal of Eating Disorders, 46, 226-232.
44. Vyvanse® (2015). Lisdexamfetamine dimesylate. Wayne, PA: Shire US Inc.
45. Wigal, T., Brams, M., Gasior, M., Gao, J., Squires, L., Giblin, J., et al., (2010). Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: Novel findings using a simulated adult workplace environment design. Behavioral and Brain Functions, 6, 34.
46. Yeomans, M. R., Leitch, M., &, Mobini, S., (2008). Impulsivity is associated with the disinhibition but not restraint factor from the Three Factor Eating Questionnaire. Appetite, 50, 469-476.